Haier Biomedical showcases automated biostorage and connected pharma solutions
Haier Biomedical highlighted automated and digital solutions for pharmaceutical R&D at ISPE Singapore 2026, as part of its transformation toward an intelligent biopharmaceutical infrastructure platform.
Haier Biomedical Accelerates Its Transformation into an Intelligent Biopharmaceutical Infrastructure Platform at ISPE Singapore 2026SINGAPORE, Sept.
1, 2026 // -- Haier Biomedical (SHA: 688139) showcased a portfolio of automated and digital solutions spanning key pharmaceutical R&D, produ…